| HBS Case Collection
(Revised from original 2004 version)
Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief executive officer, Frank Litvack, is considering alternative sources of financing to test the device.
Health Testing and Trials;
Medical Devices and Supplies Industry;
Sull, Donald N., Robert F. Higgins, Linda A. Cyr, and Bijan Salehizadeh. "Conor Medsystems." Harvard Business School Case 804-180, May 2007. (Revised from original April 2004 version.)